Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3Terminated 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Endometrial Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Melanoma 1

Interventions

pembrolizumab 8Paclitaxel 8Carboplatin 6niraparib 3Megestrol Acetate 3Cisplatin 3tislelizumab 2technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2rucaparib 2olaparib 2iso-sulfan blue 2copanlisib 2Taxes 2Surveys and Questionnaires 2Nivolumab 2Lymph Node Excision 2Indocyanine Green 2Fulvestrant 2Filgrastim 2Doxorubicin 2Docetaxel 2tremelimumab 1spartalizumab 1sonidegib 1ribociclib 1rebastinib 1pemigatinib 1nicotinamide-beta-riboside 1lenvatinib 1ixabepilone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Endometrial Neoplasms × Lymph Node Excision × Clear all
NCT01939028 2020-08-27

Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery

Case Comprehensive Cancer Center

Phase NA Terminated
58 enrolled 12 charts
Gynecologic

Endometrial Neoplasms

NCT02566811 2019-09-30

STATEC

University College, London

Phase NA Terminated
49 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡